Prevalence and impact of hyperglycemia on hospitalized leukemia patients

Susan Storey, Diane Von Ah

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hyperglycemia is a common phenomenon in hospitalized patients and has been associated with poor clinical outcomes. Hyperglycemia was defined as a fasting blood glucose ≥126mg/dL. In cancer patients' hyperglycemia has been associated with impacting diagnostic imaging studies; facilitating the development of and progression of cancers, and influencing response to treatment. Little is known about the impact of hyperglycemia on clinical outcomes such as: neutropenia, infection and hospital length of stay in hospitalized patients with leukemia. The purpose of this study was to examine the impact of hyperglycemia on the following clinical outcomes: neutropenia, infection and hospital length of stay. Methods: This retrospective study examined the prevalence and impact of hyperglycemia on clinical outcomes in this vulnerable population. Results: In this sample of 42 hospitalized patients with leukemia, 60% had at least one incidence of hyperglycemia. Patients with hyperglycemia were 1.6 times more likely (. p<0.01) to experience neutropenia than those without hyperglycemia. However, no difference was noted between those with and without hyperglycemia and risk for infection (. p=0.23). Hospital length of stay was significantly longer in patients with hyperglycemia (2 days versus 15 days; p<0.001) than those without hyperglycemia. Conclusions: The findings from this study provide preliminary evidence demonstrating hyperglycemia in the leukemia patient is common and has detrimental effects on clinical outcomes. Understanding the impact of hyperglycemia will inform interventions to mitigate its consequences and improve quality of life for patients with leukemia.

Original languageEnglish
Pages (from-to)13-17
Number of pages5
JournalEuropean Journal of Oncology Nursing
Volume19
Issue number1
DOIs
StatePublished - Feb 1 2015

Fingerprint

Hyperglycemia
Leukemia
Length of Stay
Neutropenia
Infection
Vulnerable Populations
Diagnostic Imaging
Blood Glucose
Fasting
Neoplasms
Retrospective Studies
Quality of Life

Keywords

  • Clinical outcomes
  • Hospital length of stay
  • Hyperglycemia
  • Infection
  • Leukemia
  • Neutropenia

ASJC Scopus subject areas

  • Oncology(nursing)

Cite this

Prevalence and impact of hyperglycemia on hospitalized leukemia patients. / Storey, Susan; Von Ah, Diane.

In: European Journal of Oncology Nursing, Vol. 19, No. 1, 01.02.2015, p. 13-17.

Research output: Contribution to journalArticle

@article{86fcd295a0b64b36af4e0193dbeb09da,
title = "Prevalence and impact of hyperglycemia on hospitalized leukemia patients",
abstract = "Hyperglycemia is a common phenomenon in hospitalized patients and has been associated with poor clinical outcomes. Hyperglycemia was defined as a fasting blood glucose ≥126mg/dL. In cancer patients' hyperglycemia has been associated with impacting diagnostic imaging studies; facilitating the development of and progression of cancers, and influencing response to treatment. Little is known about the impact of hyperglycemia on clinical outcomes such as: neutropenia, infection and hospital length of stay in hospitalized patients with leukemia. The purpose of this study was to examine the impact of hyperglycemia on the following clinical outcomes: neutropenia, infection and hospital length of stay. Methods: This retrospective study examined the prevalence and impact of hyperglycemia on clinical outcomes in this vulnerable population. Results: In this sample of 42 hospitalized patients with leukemia, 60{\%} had at least one incidence of hyperglycemia. Patients with hyperglycemia were 1.6 times more likely (. p<0.01) to experience neutropenia than those without hyperglycemia. However, no difference was noted between those with and without hyperglycemia and risk for infection (. p=0.23). Hospital length of stay was significantly longer in patients with hyperglycemia (2 days versus 15 days; p<0.001) than those without hyperglycemia. Conclusions: The findings from this study provide preliminary evidence demonstrating hyperglycemia in the leukemia patient is common and has detrimental effects on clinical outcomes. Understanding the impact of hyperglycemia will inform interventions to mitigate its consequences and improve quality of life for patients with leukemia.",
keywords = "Clinical outcomes, Hospital length of stay, Hyperglycemia, Infection, Leukemia, Neutropenia",
author = "Susan Storey and {Von Ah}, Diane",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.ejon.2014.08.005",
language = "English",
volume = "19",
pages = "13--17",
journal = "European Journal of Oncology Nursing",
issn = "1462-3889",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Prevalence and impact of hyperglycemia on hospitalized leukemia patients

AU - Storey, Susan

AU - Von Ah, Diane

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Hyperglycemia is a common phenomenon in hospitalized patients and has been associated with poor clinical outcomes. Hyperglycemia was defined as a fasting blood glucose ≥126mg/dL. In cancer patients' hyperglycemia has been associated with impacting diagnostic imaging studies; facilitating the development of and progression of cancers, and influencing response to treatment. Little is known about the impact of hyperglycemia on clinical outcomes such as: neutropenia, infection and hospital length of stay in hospitalized patients with leukemia. The purpose of this study was to examine the impact of hyperglycemia on the following clinical outcomes: neutropenia, infection and hospital length of stay. Methods: This retrospective study examined the prevalence and impact of hyperglycemia on clinical outcomes in this vulnerable population. Results: In this sample of 42 hospitalized patients with leukemia, 60% had at least one incidence of hyperglycemia. Patients with hyperglycemia were 1.6 times more likely (. p<0.01) to experience neutropenia than those without hyperglycemia. However, no difference was noted between those with and without hyperglycemia and risk for infection (. p=0.23). Hospital length of stay was significantly longer in patients with hyperglycemia (2 days versus 15 days; p<0.001) than those without hyperglycemia. Conclusions: The findings from this study provide preliminary evidence demonstrating hyperglycemia in the leukemia patient is common and has detrimental effects on clinical outcomes. Understanding the impact of hyperglycemia will inform interventions to mitigate its consequences and improve quality of life for patients with leukemia.

AB - Hyperglycemia is a common phenomenon in hospitalized patients and has been associated with poor clinical outcomes. Hyperglycemia was defined as a fasting blood glucose ≥126mg/dL. In cancer patients' hyperglycemia has been associated with impacting diagnostic imaging studies; facilitating the development of and progression of cancers, and influencing response to treatment. Little is known about the impact of hyperglycemia on clinical outcomes such as: neutropenia, infection and hospital length of stay in hospitalized patients with leukemia. The purpose of this study was to examine the impact of hyperglycemia on the following clinical outcomes: neutropenia, infection and hospital length of stay. Methods: This retrospective study examined the prevalence and impact of hyperglycemia on clinical outcomes in this vulnerable population. Results: In this sample of 42 hospitalized patients with leukemia, 60% had at least one incidence of hyperglycemia. Patients with hyperglycemia were 1.6 times more likely (. p<0.01) to experience neutropenia than those without hyperglycemia. However, no difference was noted between those with and without hyperglycemia and risk for infection (. p=0.23). Hospital length of stay was significantly longer in patients with hyperglycemia (2 days versus 15 days; p<0.001) than those without hyperglycemia. Conclusions: The findings from this study provide preliminary evidence demonstrating hyperglycemia in the leukemia patient is common and has detrimental effects on clinical outcomes. Understanding the impact of hyperglycemia will inform interventions to mitigate its consequences and improve quality of life for patients with leukemia.

KW - Clinical outcomes

KW - Hospital length of stay

KW - Hyperglycemia

KW - Infection

KW - Leukemia

KW - Neutropenia

UR - http://www.scopus.com/inward/record.url?scp=84922893253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922893253&partnerID=8YFLogxK

U2 - 10.1016/j.ejon.2014.08.005

DO - 10.1016/j.ejon.2014.08.005

M3 - Article

C2 - 25227459

AN - SCOPUS:84922893253

VL - 19

SP - 13

EP - 17

JO - European Journal of Oncology Nursing

JF - European Journal of Oncology Nursing

SN - 1462-3889

IS - 1

ER -